Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency. Also employed in the preparation of compounds targeting central nervous system disorders due to its ability to cross the blood-brain barrier. The compound's heterocyclic framework makes it valuable in medicinal chemistry for optimizing pharmacokinetic properties in drug design.